What to do if GobyMeds is not the right fit Not every platform is right for every patient
Endocrinology (2008) 149(2):5749.10.1210/en.2007-1292 24 Nuche-BerenguerBMorenoPPortal-NunezSDapiaSEsbritPVillanueva-PenacarrilloML
Here are some potential ways to see if Mounjaro is covered
Semaglutide is a human-derived glucagon-like peptide-1 receptor agonist recommended as a supplement to a reduced calorie diet and increased physical activity for long-term weight management in adults whose initial body mass index (BMI) falls outside the healthy range
Contraindication for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
In between-drug comparisons, tirzepatide at doses of 15 mg, 10 mg and 5 mg demonstrated greater efficacy than semaglutide at doses of 2.0 mg (MD = 4.60 kg [95% CI 7.94, 1.26]), 1.0 mg (MD = 3.53 kg [95% CI 4.80, 2.25]) and 0.5 mg (MD = 2.75 kg [95% CI 4.23, 1.28]), respectively (ESM Table 11)